83 Geschäftsbericht 2020 Lindenhofgruppe Lehre und Forschung Ist ein einziger Calprotectinwert aussagekräftig für einen zuverlässigen bzw. adäquaten Therapieentscheid? Predictive value of ultraso-nographic parameters for therapy response in Crohn’s disease and ulcerative colitis patients (TRUST BEYOND - 829) A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis (APD334-301) A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn’s Disease (BMSTYK2CD-TYK2CD / IM011-023 (Lattice)) Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod ad Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease (Ozanimod_RPC01-3201_Induction_MC + Ozanimod_RPC01-3203_Maintenance_MC) A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis (I6T-MC-AMBG_Lucent 2) A Phase 3, Multicenter, Long-Term, Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis (I6T-MC-AMAP_ Lucent 3) A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn’s Disease (I6T-MC-AMAM_Vivid 1) Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperationspartner/ Sponsor Gastroenterologie PD Dr. med. Peter Netzer MCL Medizinische Laboratorien Gastroenterologie Prof. Dr. med. Frank Seibold AbbVie Gastroenterologie Prof. Dr. med. Frank Seibold ARENA Gastroenterologie Prof. Dr. med. Frank Seibold Bristol Meyers Squibb Gastroenterologie Prof. Dr. med. Frank Seibold Celgene Gastroenterologie Prof. Dr. med. Frank Seibold Eli Lilly Gastroenterologie Prof. Dr. med. Frank Seibold Eli Lilly Gastroenterologie Prof. Dr. med. Frank Seibold Eli Lilly
RkJQdWJsaXNoZXIy MzQxOTE=